The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 24, 2017

Filed:

May. 22, 2015
Applicants:

Ulrich M. Lauer, Tuebingen, DE;

Michael Bitzer, Rottenburg, DE;

Johanna Lampe, Helsinki, FI;

Martina Schell, Tuebingen, DE;

Susanne Berchtold, Tuebingen, DE;

Sebastian Lange, Tuebingen, DE;

Wolfgang J. Neubert, Greifenberg, DE;

Sascha Bossow, Heidelberg, DE;

Inventors:

Ulrich M. Lauer, Tuebingen, DE;

Michael Bitzer, Rottenburg, DE;

Johanna Lampe, Helsinki, FI;

Martina Schell, Tuebingen, DE;

Susanne Berchtold, Tuebingen, DE;

Sebastian Lange, Tuebingen, DE;

Wolfgang J. Neubert, Greifenberg, DE;

Sascha Bossow, Heidelberg, DE;

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/768 (2015.01); C12N 9/10 (2006.01); C12N 9/78 (2006.01); A61K 31/7088 (2006.01); C12N 7/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/768 (2013.01); A61K 31/7088 (2013.01); C12N 7/00 (2013.01); C12N 9/1077 (2013.01); C12N 9/78 (2013.01); C07K 2319/00 (2013.01); C12N 2760/18421 (2013.01); C12N 2760/18432 (2013.01); C12N 2760/18443 (2013.01); C12N 2760/18471 (2013.01); C12N 2830/60 (2013.01); C12Y 305/04001 (2013.01);
Abstract

The present invention pertains to a pharmaceutical composition comprising a recombinant measles virus encoding a suicide gene for use in the treatment of malignant cells with primary or secondary resistances against an oncolytic measles virus without suicide gene activity. Further, the present invention pertains to a recombinant measles virus based on measles vaccine strain Schwarz encoding a suicide gene, which comprises a fusion of a cytosine deaminase, particularly yeast cytosine deaminase, and a uracil phosphoribosyltransferase, particularly yeast uracil phosphoribosyltransferase, to a method and a kit for preparing the recombinant measles virus as claimed herein.


Find Patent Forward Citations

Loading…